REGEND001 Autologous Basal Layer Stem Cell Transplantation for Interstitial Lung Disease (ILD): A Translational Application Study

Clinical trial NCT06998706 · RECRUITING

Trial details

NCT number: NCT06998706
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Interstitial Lung Disease (ILD)

Start date: 2025-06-19
Primary completion: 2029-06-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.